Mihaela Mihailescu, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4440 W 95th St, Oak Lawn, IL 60453 Phone: 708-684-8000 |
Suliman Alradawi, M.D Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4220 W 95th St Ste 200, Oak Lawn, IL 60453 Phone: 708-398-0282 Fax: 708-398-0281 |
Ms. Alexandra Popescu, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 6311 W 95th St, Oak Lawn, IL 60453 Phone: 708-581-7380 Fax: 708-581-7385 |
Phyllis N Bonaminio, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5540 W 111th St, Oak Lawn, IL 60453 Phone: 708-423-8440 Fax: 708-658-2962 |
News Archive
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE(bortezomib), which updates the label to include the subcutaneous method of administration in all approved indications: multiple myeloma and mantle cell lymphoma after at least one prior therapy.
A new review of recent studies suggests there are some benefits to inducing labor in women whose water breaks at the point of full-term pregnancy but before the start of labor.
More than 10 percent of patients waiting for a liver transplant die each year. This observational study looked at trends in the transplantation of livers from older donors and outcomes in recipients of these older livers from 2003 to 2016.
A receptor that is present in the nucleus of cells can, when activated, slow the growth of tamoxifen-resistant breast cancer cells, a new study found. The study built on the recent discovery that farnesoid X receptor — a nuclear receptor found mainly in the liver — is found in breast cancer tissue.
In an average kindergarten class of 30 students, about two are experiencing developmental language disorder, meaning they learn language more slowly than their peers. While DLD is just as common as dyslexia or ADHD, fewer people have heard of the disorder, and less research and funding go into developing effective interventions.
› Verified 1 days ago